This specialty practice discussion group is intended for discussion of inpatient staff hospital... View more
This specialty practice discussion group is intended for discussion of inpatient staff hospital issues. Remember that anything published in this community can be seen by any member of the community. Please be considerate of the HIPAA Privacy Rule when posting to the community.
Are you sure you want to leave ?
Reply To: Blinatumomab, Dinutuximab, and Other Biotherapy Nurse Staffing Ratios
Hello! I work in as a charge nurse in an inpatient pediatric unit for Kaiser Permanente, Fontana Medical Center in So Cal. Our nurse patient ratio for Blinatumomab, Dinutuximab, and Rituximab is 1:1. Blinatumomab and Dinutuximab are given in the PICU setting. Please share and literature that you have found that supports in patient staffing ratios. Thank you for for starting this thread!
—————————— Divina Perez, MSN, BSN, RN, CPN Corona, CA Charge Nurse Pediatrics Kaiser Permanente Fontana Medical Center Fontana, CA United States —————————— ——————————————- Original Message: Sent: 08-30-2022 07:34 AM From: Alyssa Henderson Subject: Blinatumomab, Dinutuximab, and Other Biotherapy Nurse Staffing Ratios
Hello everyone! I am the assistant nurse manager at Hackensack UMC in Hackensack, NJ and I am looking for documentation to support my inpatient unit’s 1:2 nurse:patient staffing ratio for blinatumomab, dinutuximab, and other biotherapy infusions. I am in the process of conducting a literature search but not having much luck. Would you mind sharing your hospital name and pediatric biotherapy infusion staffing ratios (specifically blina & dinutux if possible)? Also, if anyone has literature to support lower staffing ratios for these infusions I would sincerely appreciate it! Thank you in advance!!